home All News open_in_new Full Article

Lilly sube un 170% el precio en Reino Unido de su antiobesidad

La farmacéutica norteamericana Lilly aumentará hasta en un 170% el precio de lista (el máximo recomendado para su venta al público) de Mounjaro, su inyectable para la pérdida de peso y la diabetes tipo 2. Leer


today 29 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 160890483
Add Watch Country

arrow_drop_down